{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03386708",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SCLnow-XY-01"
      },
      "Organization": {
        "OrgFullName": "Sclnow Biotechnology Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury",
      "OfficialTitle": "A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cell (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury"
    },
    "StatusModule": {
      "StatusVerifiedDate": "September 2021",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "October 1, 2018",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 1, 2021",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 21, 2021",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "December 12, 2017",
      "StudyFirstSubmitQCDate": "December 21, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "December 29, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "September 21, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 27, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Sclnow Biotechnology Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Healing Poor after Uterus Injury, and exploring the possible mechanisms of umbilical cord mesenchymal stem cell therapy in Healing Poor After Uterus Injury disease",
      "DetailedDescription": "This is a random, open label, and parallel controled experiment. 40 patients are selected and sign consent forms, then divided into four groups. Doctors collect the basic information of patient (including age,height, mental condition, vital sign, history of disease, pharmaco-history, and so on.), evaluate the symptom of healing Poor after Uterus Injury (Menstrual conditions, Visual analogue scale, pregnancies).\n\nAll patients receive laboratory and image examination as baseline. Then, cell treatment will be given based on the clinical protocol. Doctors have follow-up visit on 1, 2, 3, 6, and 12 month after treatment, and do efficacy evaluation."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Uterus; Injury"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Healing Poor After Uterus Injury, Mesenchymal Stem Cell"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "40",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "hUC-MSC intrauterine injection group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Human umbilical cord mesenchymal stem cells (hUC-MSC) (SCLnow 19#)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: intrauterine injection",
                "Biological: umbilical cord mesenchymal stem cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "NS intrauterine injection group",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Normal saline (NS) (2ml)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: intrauterine injection",
                "Drug: Normal saline (NS)"
              ]
            }
          },
          {
            "ArmGroupLabel": "hUC-MSC intravenous injection group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Umbilical cord mesenchymal stem cells (SCLnow 19#)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: intravenous injection",
                "Biological: umbilical cord mesenchymal stem cell"
              ]
            }
          },
          {
            "ArmGroupLabel": "NS intravenous injection group",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Normal saline (NS) (30ml)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: intravenous injection",
                "Drug: Normal saline (NS)"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Procedure",
            "InterventionName": "intrauterine injection",
            "InterventionDescription": "intrauterine injection with umbilical cord mesenchymal stem cell (SCLnow 19#); one time/ 15 days, total 4 times",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "NS intrauterine injection group",
                "hUC-MSC intrauterine injection group"
              ]
            }
          },
          {
            "InterventionType": "Procedure",
            "InterventionName": "intravenous injection",
            "InterventionDescription": "intravenous injection with umbilical cord mesenchymal stem cell (SCLnow 19#); one time/ 15 days, total 4 times",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "NS intravenous injection group",
                "hUC-MSC intravenous injection group"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "umbilical cord mesenchymal stem cell",
            "InterventionDescription": "Treat patients with umbilical cord mesenchymal stem cell (SCLnow 19#), intrauterine injection: 2 * 10^7 cells (2ml)/ intravenous injection: 4 * 10^7 cells (30ml)",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "hUC-MSC intrauterine injection group",
                "hUC-MSC intravenous injection group"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Normal saline (NS)",
            "InterventionDescription": "Treat patient with Normal saline (NS): 2ml/30ml",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "NS intrauterine injection group",
                "NS intravenous injection group"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "placebo group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Intrauterine adhesion patients efficacy evaluation",
            "PrimaryOutcomeDescription": "Evaluate the efficacy by calculating the thickness of endometrium, the equation is, Efficacy = (thickness of endometrium after treatment - thickness of endometrium before treatment)/thickness of endometrium before treatment * 100%\n\nClassified the efficacy in 4 grade as follow, A. Recovery, efficacy 86% - 100%; B. Obvious improve, efficacy 46% - 85%; C. Improve, efficacy 16% -45%; D. Invalid, efficacy < 16% Grade A, B, and C is proposed to be effective.",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Incision lacuna and incision diverticulum patients efficacy evaluation",
            "SecondaryOutcomeDescription": "Evaluate the efficacy by calculating the 50% or more reduction, the equation is, Efficacy = (Area of lacuna and diverticulum after treatment - Area of lacuna and diverticulum after treatment before treatment)/Area of lacuna and diverticulum before treatment * 100%.\n\nClassified the efficacy in 4 grade as follow, A. Recovery, efficacy 86% - 100%; B. Obvious improve, efficacy 46% - 85%; C. Improve, efficacy 16% -45%; D. Invalid, efficacy < 16% Grade A, B, and C is proposed to be effective.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Ultrasound of uterus evaluation",
            "SecondaryOutcomeDescription": "Ultrasound of uterus. Compare with the baseline images, evaluate the changes/improvement after cell treatment.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Hysteroscopy evaluation",
            "SecondaryOutcomeDescription": "Do hysteroscopy examination, compare with the baseline images, evaluate the change/improvement after cell treatment.",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Pain score",
            "SecondaryOutcomeDescription": "Measure the pain score of patients by Visual Analog Score (VAS) for pain",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nFemale, with BMI 19-25 kg/m^2\nMeet the clinical standard of Healing Poor After Uterus Injury\nNon smoker\nDo not accept stem cells treatment in 6 months\nParticipants or their family members sign the consent form of this study\n\nExclusion Criteria:\n\nPregnant or breast feeding women\nAge <18 or >50\nRefuse to sign the consent form\nPatients with underlying risk of medical disease history: history of diabetes, serious cardiovascular disease, severe infection, alimentary tract hemorrhage, etc.\nSerum with HIV, syphilis antibody positive\nSevere mental disease, cognitive disorder patients\nOther severe system or organ organic disease\nParticipate other clinical experiments in 3 months\nOvarian and pituitary dysfunction diseases\nWith some other conditions that doctor propose not to participate",
      "HealthyVolunteers": "No",
      "Gender": "Female",
      "MinimumAge": "18 Years",
      "MaximumAge": "50 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Weishe Zhang",
            "OverallOfficialAffiliation": "Xiangya Hospital of Central South University",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Xiangya Hospital Central South University",
            "LocationCity": "Changsha",
            "LocationState": "Hunan",
            "LocationZip": "410008",
            "LocationCountry": "China"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000014947",
            "ConditionMeshTerm": "Wounds and Injuries"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M16837",
            "ConditionBrowseLeafName": "Wounds and Injuries",
            "ConditionBrowseLeafAsFound": "Injury",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC26",
            "ConditionBrowseBranchName": "Wounds and Injuries"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}